All data are based on the daily closing price as of January 12, 2026
s

Solasto

6197.TSE
5.44 USD
-0.11
-1.98%

Overview

Last close
5.44 usd
Market cap
499.25M usd
52 week high
5.70 usd
52 week low
2.76 usd
Target price
3.41 usd

Valuation

P/E
10.8682
Forward P/E
N/A
Price/Sales
0.562
Price/Book Value
3.27
Enterprise Value
537.23M usd
EV/Revenue
0.6092
EV/EBITDA
8.3051

Key financials

Revenue TTM
876.73M usd
Gross Profit TTM
142.11M usd
EBITDA TTM
63.77M usd
Earnings per Share
0.3 usd
Dividend
0.13 usd
Total assets
465.84M usd
Net debt
44.38M usd

About

Solasto Corporation provides medical outsourcing services to medical institutions in Japan. It operates through the Medical Business, Nursing Care Business, Children's Business, and Others segments. The Medical Business segment offers medical administration, medical affairs, and hospital management support services, as well as various surveys and analyses in the fields of medical administration and hospital management, document preparation, lectures and training, and educational courses on medical administration services. Its Nursing Care Business segment provides nursing care services, including nursing homes, residential nursing homes, and serviced housing for the elderly, as well as day care and home help services. The Children's Business segment offers childcare services, such as licensed, certified, and small-scale childcare centers, as well as childcare centers for recovering children. Its Others segment operates its smart hospital business that provides remote medical fee billing services to medical institutions. Solasto Corporation was formerly known as N.I.C Corporation. The company was founded in 1965 and is headquartered in Tokyo, Japan.
  • Symbol
    6197.TSE
  • Exchange
    TSE
  • Isin
    JP3436250009
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
    Mr. Yoshikazu Fujikawa
  • Headquarter
    Tokyo
  • Web site
    https://www.solasto.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top